Latest filing published 01 Nov 2021 for Augmedix, Inc., €1.5M.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
DCM VI, L.P.: trading record in brief
This profile gathers the share dealings of DCM VI, L.P. in Augmedix, Inc. We count 4 filings; the first trade dates from 5 October 2020 and the latest from 28 October 2021.
The open-market record is one-sided, with 2 purchases worth €3.2M and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 2 share grants. Since January 2021: 1 purchase and no sales on the market.
The newest entry dates from 1 November 2021: an open-market purchase of €1.5M, in Augmedix, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to DCM VI, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 437,500 shares@ US$4.00100.0% of flowCommon StockSEC:0001213900-21-055917:0Canonical exit: 26 Jan 2022 (T+90)
- 3,064,751 sharesCommon StockSEC:0001209191-20-054209:0
- 666,667 shares@ US$3.00Common StockSEC:0001209191-20-054209:1Canonical exit: 3 Jan 2021 (T+90)
- 20,007 sharesCommon StockSEC:0001209191-20-054209:2
4 of 4 declarations